Lataa...
Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic
BACKGROUND: Immunomodulatory therapy (IMT) is often considered for systemic treatment of non-infectious uveitis (NIU). During the evolving coronavirus disease-2019 (COVID-19) pandemic, given the concerns related to IMT and the increased risk of infections, an urgent need for guidance on the manageme...
Tallennettuna:
| Julkaisussa: | Br J Ophthalmol |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7313529/ https://ncbi.nlm.nih.gov/pubmed/32586933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2020-316776 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|